Bolt Biotherapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BOLT and other ETFs, options, and stocks.

About BOLT

Bolt Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. Its pipeline includes BDC-1001, a HER2-targeting Boltbody Immune-Stimulating Antibody Conjugate (ISAC), BDC-3042, a myeloid-modulating antibody, and multiple Boltbody ISAC collaboration programs. 

CEO
William P. Quinn
CEOWilliam P. Quinn
Employees
23
Employees23
Headquarters
Redwood City, California
HeadquartersRedwood City, California
Founded
2015
Founded2015
Employees
23
Employees23

BOLT Key Statistics

Market cap
7.72M
Market cap7.72M
Price-Earnings ratio
-0.24
Price-Earnings ratio-0.24
Dividend yield
—
Dividend yield—
Average volume
27.67K
Average volume27.67K
High today
$4.48
High today$4.48
Low today
$3.96
Low today$3.96
Open price
$4.48
Open price$4.48
Volume
10.07K
Volume10.07K
52 Week high
$7.20
52 Week high$7.20
52 Week low
$3.10
52 Week low$3.10

Stock Snapshot

As of today, Bolt Biotherapeutics(BOLT) shares are valued at $4.00. The company's market cap stands at 7.72M, with a P/E ratio of -0.24.

During the trading session on 2026-10-18, Bolt Biotherapeutics(BOLT) shares reached a daily high of $4.48 and a low of $3.96. At a current price of $4.00, the stock is +1.1% higher than the low and still -10.7% under the high.

Trading volume for Bolt Biotherapeutics(BOLT) stock has reached 10.07K, versus its average volume of 27.67K.

The stock's 52-week range extends from a low of $3.10 to a high of $7.20.

The stock's 52-week range extends from a low of $3.10 to a high of $7.20.

People also own

Based on the portfolios of people who own BOLT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.